retatrutide type 2 diabetes phase 2 results 2024 ada trial demonstrate benefits of in obesity, diabetes, NASH Efficacy and Safety of Retatrutide – Effects of retatrutide, dulaglutide, and

A 2022 systematic review found the incidence of acute pancreatitis in GLP-1 clinical trials ranged from 0.1% to 0.3%, comparable to or lower than placebo groups in some studies

The medication slows stomach emptying, which keeps you feeling full longer after eating

Damaging effects of hyperglycemia on cardiovascular function: Spotlight on glucose metabolic pathways

Depending on the current health of your kidneys, there may be risks and benefits to taking B12

How to write a prescription for adult patients in the e-prescribing system Starting with Victoza 0.6 mg Victoza (18 mg/3 mL) Sig: Inject 0.6 mg SC once daily for at least 7 days Quantity: 6 mL (2-pen box) Starting with Victoza 1.2 mg Victoza (18 mg/3 mL) Sig: Inject 1.2 mg SC once daily for at least 7 days Quantity: 6 mL (2-pen box) 1.8 mg Victoza (18 mg/3 mL) Sig: Inject 1.8 mg SC once daily Quantity: 9 mL (3-pen box) Pediatric (10 years) dosing instructions 1